Hemodynamic safety of remimazolam vs propofol in elderly patients.

Tahir N, Khan A, Faryal S, Faizan M, Irshad A, Iqbal U, Wasay M, Arsal SA, Kumar A, Okon II, Amin SB

Open source

DOI
10.4292/wjgpt.120256
Published
2026 Sep 5
Container
World journal of gastrointestinal pharmacology and therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4292/wjgpt.120256,
  title = {Hemodynamic safety of remimazolam vs propofol in elderly patients.},
  author = {Tahir N and Khan A and Faryal S and Faizan M and Irshad A and Iqbal U and Wasay M and Arsal SA and Kumar A and Okon II and Amin SB},
  year = {2026},
  journal = {World journal of gastrointestinal pharmacology and therapeutics},
  doi = {10.4292/wjgpt.120256},
  url = {https://doi.org/10.4292/wjgpt.120256}
}

RIS

TY  - JOUR
TI  - Hemodynamic safety of remimazolam vs propofol in elderly patients.
AU  - Tahir N
AU  - Khan A
AU  - Faryal S
AU  - Faizan M
AU  - Irshad A
AU  - Iqbal U
AU  - Wasay M
AU  - Arsal SA
AU  - Kumar A
AU  - Okon II
AU  - Amin SB
PY  - 2026
JO  - World journal of gastrointestinal pharmacology and therapeutics
DO  - 10.4292/wjgpt.120256
UR  - https://doi.org/10.4292/wjgpt.120256
ER  - 

APA

N, T., A, K., S, F., M, F., A, I., U, I., M, W., SA, A., A, K., II, O., & SB, A. (2026). Hemodynamic safety of remimazolam vs propofol in elderly patients.. World journal of gastrointestinal pharmacology and therapeutics. https://doi.org/10.4292/wjgpt.120256

Source records